Brazil's A.C.Camargo Cancer Center Adopts Masimo SpHb for Noninvasive and Continuous Hemoglobin Monitoring

Masimo MASI announced today that A.C.Camargo Cancer Center in Sao Paulo, Brazil has installed Masimo's noninvasive and continuous hemoglobin (SpHb®) technology to monitor surgical patients. Clinicians use invasive blood sampling and laboratory analysis of hemoglobin to determine hemoglobin levels and help estimate blood loss to determine need for red blood cell transfusions. However, lab-based hemoglobin is only available intermittently and results are often delayed. SpHb offers real-time visibility to changes – or lack of changes – in hemoglobin between invasive blood sampling. "The data associating transfusion with higher mortality rates was clear, so we knew we had to implement strategies to reduce See full press release
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsContractsM&APress ReleasesHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!